Raymond James & Associates Boston Scientific Corp Transaction History
Raymond James & Associates
- $161 Billion
- Q3 2024
A detailed history of Raymond James & Associates transactions in Boston Scientific Corp stock. As of the latest transaction made, Raymond James & Associates holds 1,327,349 shares of BSX stock, worth $125 Million. This represents 0.07% of its overall portfolio holdings.
Number of Shares
1,327,349
Previous 1,152,055
15.22%
Holding current value
$125 Million
Previous $88.7 Million
25.37%
% of portfolio
0.07%
Previous 0.06%
Shares
30 transactions
Others Institutions Holding BSX
# of Institutions
1,691Shares Held
1.18BCall Options Held
8.76MPut Options Held
9.42M-
Vanguard Group Inc Valley Forge, PA133MShares$12.5 Billion0.21% of portfolio
-
Black Rock Inc. New York, NY126MShares$11.9 Billion0.22% of portfolio
-
State Street Corp Boston, MA64MShares$6.03 Billion0.23% of portfolio
-
Primecap Management CO Pasadena, CA36.9MShares$3.48 Billion2.61% of portfolio
-
Geode Capital Management, LLC Boston, MA30.6MShares$2.89 Billion0.22% of portfolio
About BOSTON SCIENTIFIC CORP
- Ticker BSX
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,431,609,984
- Market Cap $135B
- Description
- Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...